Avraham Ben Tzvi Indaptus Therapeutics, Inc. (INDP) insider trading activity

INDP Quotes by TradingView

Avraham Ben Tzvi is Director of Indaptus Therapeutics, Inc.. Currently has a direct ownership of 25,100 shares of INDP, which is worth approximately $63,000. The most recent transaction as insider was on Jan 20, 2026, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.1K
n/a 3M change
n/a 12M change
Total Value Held $63,000

Avraham Ben-Tzvi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 20 2026
BUY
Grant, award, or other acquisition
-
25,000 Added 49.9%
25,100 Common Stock

Also insider at

OPGN
OPGEN INC Healthcare
Director
MINM
MINIM, INC. Technology
Director
CYCC
Cyclacel Pharmaceuticals, Inc. Healthcare
Director
TTNP
TITAN PHARMACEUTICALS INC Healthcare
Director
AB

Avraham Ben Tzvi

Director
Efrat, L3

Track Institutional and Insider Activities on INDP

Follow Indaptus Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INDP shares.

Notify only if

Insider Trading

Get notified when an Indaptus Therapeutics, Inc. insider buys or sells INDP shares.

Notify only if

News

Receive news related to Indaptus Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INDP